北米サルコペニア治療市場予測 2030年 - 地域分析 - 治療タイプ別（ビタミンDおよびカルシウムサプリメント、タンパク質サプリメント、ビタミンB12サプリメントなど）および流通チャネル別（薬局、小売チャネル、オンラインチャネルなど）
高齢者人口の増加が北米のサルコペニア治療市場を活性化
高齢者人口は、サルコペニア、整形外科疾患、代謝疾患、神経疾患などにかかりやすい傾向があります。サルコペニアは、骨格筋の量と強度が徐々に低下する特徴を持つ老年病です。転倒、障害、施設入所、生活の質の低下、死亡率など、健康状態が悪化するリスクが高くなります。先進国では高齢者人口が急速に増加しています。世界保健機関（WHO）によると、世界中の高齢化人口は2019年の約10億人から2050年までに約21億人に増加すると見込まれています。また、2020年の国勢調査によると、1920年から2020年までの100年間に、米国の65歳以上の人口は総人口の約5倍の速さで増加しました。2020年には、高齢者人口は5,580万人に達し、米国の総人口の16.8％を占めました。
加齢により、体組成の大きな変化の1つとして筋肉量が減少します。高齢者の食物摂取量の大幅な減少は、筋肉量の減少を引き起こす主な要因の1つです。国立医学図書館によると、50〜60歳の年齢層の人々は毎年約1.5％の筋力を失い、60歳以降は毎年1〜2％の筋肉量が失われます。一般人口と比較して、高齢患者のサルコペニアの有病率は高かった。2023年6月にエルゼビアで発表された記事によると、サルコペニアの有病率は、糖尿病患者の18％から不治の食道がん患者の66％に及ぶ。したがって、高齢者人口の増加は、サルコペニア治療市場の成長に大きく貢献しています。
北米のサルコペニア治療市場の概要
北米のサルコペニア治療市場は、米国、カナダ、メキシコに分割されています。 2022年には北米が世界市場で最大のシェアを占めました。北米におけるサルコペニア治療市場の成長は、治療のための栄養補助食品の採用増加に起因しています。さらに、高齢者人口におけるビタミンB12およびビタミンD欠乏症の症例数の増加に伴う整形外科疾患の有病率の急増も、この地域の市場を活性化させています。
サルコペニアの有病率は年齢と性別によって異なりますが、米国の介護施設やコミュニティに住む高齢者は、この病気を発症するリスクが高くなります。国立衛生研究所によると、2019年の米国のサルコペニア患者の入院費用の予想額は404億米ドルでした。サルコペニアの人は、正常な筋肉量と機能を持つ人よりも、平均して毎年2,315米ドル多く病院に通院しており、サルコペニアのない人よりも入院する可能性がほぼ2倍です。さらに、骨格筋の損失が 10% 減少すると、サルコペニアの併存疾患の可能性を防ぎ、米国の年間医療費を約 10 億米ドル節約できます。
北米のサルコペニア治療市場の収益と 2030 年までの予測 (百万米ドル)
北米のサルコペニア治療市場のセグメンテーション
北米のサルコペニア治療市場は、治療タイプ、流通チャネル、国に分類されています。
治療タイプに基づいて、北米のサルコペニア治療市場は、ビタミン D とカルシウムのサプリメント、タンパク質サプリメント、ビタミン B12 サプリメント、その他に分類されています。 ビタミン D とカルシウムのサプリメントセグメントは、2022 年に北米のサルコペニア治療市場で最大のシェアを占めました。
流通チャネルの面では、北米のサルコペニア治療市場は、薬局、小売チャネル、オンラインチャネル、その他に分類されています。薬局セグメントは、2022年に北米のサルコペニア治療市場で最大のシェアを占めました。
国別に見ると、北米のサルコペニア治療市場は米国、カナダ、メキシコに分かれています。2022年には米国が北米のサルコペニア治療市場シェアを独占しました。
Abbott Laboratories、Bayer AG、Metagenics LLC、Nestle Health Science SA、Novartis AG、Pfizer Inc、Sanofi SA、Amway Corp、GSK Plc、Makers Nutrition LLCは、北米のサルコペニア治療市場で事業を展開している大手企業の一部です。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Sarcopenia Treatment Market - Key Industry Dynamics
4.1 North America Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - North America Market Analysis
5.1 North America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 North America Sarcopenia Treatment Market Forecast and Analysis
6. North America Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. North America Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : North America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. North America Sarcopenia Treatment Market - Country Analysis
8.1 North America
8.1.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Makers Nutrition LLC
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. North America Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - By Treatment Type
Table 5. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. North America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 15. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. North America Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. North America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. North America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : North America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. North America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. North America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. United States Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. Canada Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. Mexico Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Bayer AG
3. Metagenics LLC
4. Nestle Health Science SA
5. Novartis AG
6. Pfizer Inc
7. Sanofi SA
8. Amway Corp
9. GSK Plc
10. Makers Nutrition LLC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.